info@synchemia.com | sales@synchemia.com 
9766925136 
Regorafenib
Regorafenib | CAS NO: 755037-03-7 , Regorafenib (Stivarga) is an oral anti-cancer drug used for specific advanced cancers that haven't responded to other treatments, primarily metastatic colorectal cancer, hepatocellular carcinoma (liver cancer), and gastrointestinal stromal tumors (GIST), working by blocking signals that help cancer cells multiply. It's prescribed for patients whose cancer has progressed after standard therapies, like chemotherapy or other targeted drugs.
We are the Synchemia Research Chemical specializes in manufacturing and supplying of Regorafenib impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities. Regorafenib (Stivarga) is an oral anti-cancer drug used for specific advanced cancers that haven't responded to other treatments, primarily metastatic colorectal cancer, hepatocellular carcinoma (liver cancer), and gastrointestinal stromal tumors (GIST), working by blocking signals that help cancer cells multiply. It's prescribed for patients whose cancer has progressed after standard therapies, like chemotherapy or other targeted drugs. Buy Reliable and High-Purity Regorafenib Impurities, Delivered by Synchemia Research Chemicals.
Download catalogue
Pharmaceutical Reference Standards
| CAT No | SRC-R79147 |
| CAS No | 1209459-88-0 |
| Mol.F. | C7H7BrN2O |
| Mol.Wt. | 215.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R79148 |
| CAS No | 611226-36-9 |
| Mol.F. | C7H8N2O2 |
| Mol.Wt. | 152.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R79149 |
| CAS No | 1446410-29-2 |
| Mol.F. | C8H10ClN3O |
| Mol.Wt. | 199.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R79150 |
| CAS No | 2711-21-9 |
| Mol.F. | C10H10ClF3N2O |
| Mol.Wt. | 266.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R79151 |
| CAS No | 2098799-12-1 |
| Mol.F. | C19H17FN4O3 |
| Mol.Wt. | 368.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R79152 |
| CAS No | 2817629-89-1 |
| Mol.F. | C12H9FN2O3 |
| Mol.Wt. | 248.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R79153 |
| CAS No | 757251-54-0 |
| Mol.F. | C12H10FN3O2 |
| Mol.Wt. | 247.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R79154 |
| CAS No | 864245-61-4 |
| Mol.F. | C13H11FN2O3 |
| Mol.Wt. | 262.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R79155 |
| CAS No | 2817629-88-0 |
| Mol.F. | C14H13FN2O3 |
| Mol.Wt. | 276.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R79156 |
| CAS No | 1020173-15-2 |
| Mol.F. | C16H17FN2O3 |
| Mol.Wt. | 304.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R79157 |
| CAS No | 42265-69-0 |
| Mol.F. | C8H7ClF3N |
| Mol.Wt. | 209.6g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R79158 |
| CAS No | NA |
| Mol.F. | C22H12Cl2F7N3O3 |
| Mol.Wt. | 570.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R79159 |
| CAS No | 2518416-73-2 |
| Mol.F. | C22H12Cl2F7N3O3 |
| Mol.Wt. | 570.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R79160 |
| CAS No | NA |
| Mol.F. | C23H11Cl3F9N3O2 |
| Mol.Wt. | 638.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R79161 |
| CAS No | NA |
| Mol.F. | C14H9ClF4N2O2 |
| Mol.Wt. | 348.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R79162 |
| CAS No | 2518234-85-8 |
| Mol.F. | C25H19F2N5O4 |
| Mol.Wt. | 491.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.
